Back

Salarius Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Read More

Back

Salarius Pharmaceuticals to Present at the Noble Capital Markets’ 16th Annual Small & Microcap Investor Conference

Read More

Back

Salarius Announces Pricing of $9.6 Million Underwritten Public Offering

Read More

Back

Salarius Pharmaceuticals to Present at the BIO CEO & Investor Conference

Read More

Back

Salarius Announces Publication of Scientific Paper Highlighting Potential of Combining Seclidemstat with Checkpoint Inhibitors

Read More